Understanding Treatment Goals for Patients With Onychomycosis

Slides:

Advertisements

Similar presentations

Welcome to A Day of Derm for GPs, thank you so much for joining us today in Ajax (you may want to add something related to the weather ie. Thank you fo.

Advertisements

INNOVATIVE TOPICAL ANTIFUNGAL. ONYCHOMYCOSIS Fungal Infection of nails and toes Caused by dermatophytes Infect the nail plate and nail bed Causes nails.

Tinea Pedis Natural History & Clinical Trials Joseph Porres, M.D., Ph.D. Medical Officer, DDDDP.

Upfront Combination Therapy vs Step-Up Approach for PAH:

Symptom Control and Enhancing Functioning in Schizophrenia

The Patient Experience With Systemic Lupus Erythematosus

Onychomycosis An update on epidemiology, clinical evaluation

The Nurse View: Management of Pancreatic Cancer

Chronic HCV Infection and CKD

Endocrine Combinations in HR-Positive MBC: The Future Is Now

How the Latest Data in MDD Can Guide Treatment Decisions:

NOACs for Cancer-Associated Thrombosis:

Chronic Hepatitis C Virus Infection

Goals of Therapy for Patients With UC

Introducing JAK Inhibitors in Rheumatoid Arthritis

Thrombosis, Cancer, and NOACs

Expert Perspectives on Clinically Challenging Cases in Narcolepsy

Progression After Cancer Immunotherapy in Advanced NSCLC

Moderate-Intensity Statins for Dyslipidemia: How to Treat Today?

Ask the Onychomycosis Expert, Part 2

Ask the Onychomycosis Expert, Part 1

The HCV Revolution: Are You and Your Practice Ready?

Optimizing Outcomes in the Management of GIST

SGLT2 Inhibitors in the Modern Era: Why and Where?

Before and After: Patient Cases in Onychomycosis

Activity Goals. Activity Goals Discussion Topics.

Complicated Cases in Ulcerative Colitis

Therapeutic Strategies in the Management of Mild-to-Moderate Atopic Dermatitis.

The Resurgence of Topical Treatments Across a Spectrum of Psoriasis

Decision-making in the eRA of Treating to Target

Translating Atopic Dermatitis

Managing gBRCA-Positive Metastatic Breast Cancer

WHO Clinical Classification of PH Complex Cases in PH.

Patient Case: KC. Optimizing Treatment of Mild to Moderate Ulcerative Colitis: A Case-Based Perspective.

What Is the Role of Injectables in the Modern Era of MS Treatment?

Antithrombotic Protection in CAD and HF

Advancing the Treatment of IBD With Biologics

Use of Combination of Saxagliptin/ Dapagliflozin in Patients With Poorly Controlled Diabetes on Metformin.

Treatment of Thromboembolic Disease The Need for Multiple Perspectives

Treating CD30-Expressing Cutaneous T-Cell Lymphoma

When Is Intrathecal Drug Delivery Appropriate?

Understanding and Addressing the Needs of Patients With AD

Cancer-Associated Thrombosis

Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from.

Updates on the Prevention and Management of CINV

A Guideline-Based Approach to HCV Care

Are We Making Progress in the Management of Huntington Disease?

PEARLS OF WISDOM WITH COMBINATION THERAPY IN PAH

Addressing Treatment Challenges in Cystic Fibrosis

Incorporating Prostacyclins Into Practice

Challenges in LA SCCHN.

Presentation of Onychomycosis

Introduction. Emerging Treatments for Thrombocytopenia in Adults With CLD Requiring Elective Invasive Procedures.

Treating Atypical Hemolytic Uremic Syndrome A Case Discussion

Clinical Challenges and Updates in Managing Seizure Clusters

Assessing the Burden of Hyperkalemia

When Is Intrathecal Drug Delivery Appropriate?

Optimizing Outcomes for Patients With Systemic Lupus Erythematosus: Key Considerations.

Optimizing Front-Line Endocrine Therapy in Metastatic Breast Cancer

Assessing the Burden of Hyperkalemia

Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.

Anemia Explored.

My PAH Patient.

Ask the Psoriasis Expert

The Power of As-Treated Analyses

Presentation transcript:

Understanding Treatment Goals for Patients With Onychomycosis

Program Goals

What Is Onychomycosis?

What Is Onychomycosis? (cont)

Mild Onychomycosis

Moderate Onychomycosis

Severe Onychomycosis With Tinea Pedis

Presentation of Onychomycosis

Treatment Challenges

Treatment Challenges (cont)

Why Treat Onychomycosis? (cont)

Why Treat Onychomycosis? (cont)

Clinical Trial End Points: Complete Cure

Clinical Trial End Points: Mycologic Cure

Clinical Trial End Points: Questions and Issues

A New Era

Oral Antifungals

Oral Antifungals (cont)

Oral Antifungals: Safety Issues

Oral Antifungals: Safety Issues

Ciclopirox

New Topical Antifungals

New Topical Antifungals (cont)

Efinaconazole

Efinaconazole (cont)

Efinaconazole Cure Rates

Efinaconazole Cure Rates (Cont)

Efinaconazole Safety

Clinical Trials: Tavaborole

Tavaborole Cure Rates

Tavaborole Cure Rates (cont)

Tavaborole Safety

New Antifungal Solutions in Practice

Abbreviations

References

References (cont)

References (cont)

References (cont)